ibrutinib,venetoclax
roche,janssen,abbvie
['4627', 'leusm', 'cll', 'venetoclax', 'glow', '2019']
#glow first time demonstration of os improvement of i+v vs o-chl (despite salvage with novel agents). time when you give targeted therapies matters in #cll #ash22 #cllsm #leusm 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @EHA_Hematology. Chair, SWG “Aging and Hematology”. @ASH_hematology IMC member